The Henry Ford Department of Medicine has 12 divisions, 11 clinical divisions each with academic and research efforts and one basic science division devoted to cardiac-renal hypertension research. Our clinicians staff Henry Ford Hospital in Detroit and Henry Ford West Bloomfield Hospital in Oakland County, with some subspecialty division staff providing service at Henry Ford Wyandotte Hospital in the Downriver community and Henry Ford Macomb Hospital in Clinton Township. Outpatient clinical services for the Department are offered at numerous Henry Ford Medical Centers located across southeast Michigan.

The Division of Allergy and Immunology specializes in the diagnosis and management of asthma, food allergy, hayfever, allergic skin conditions, and immune deficiencies from birth to the elderly. The Henry Ford Center for Asthma, Allergy and Immunology Research (CAAIR) includes the Division’s investigators and others from the Department of Public Health Sciences at Henry Ford Health System. Allergy and immunology research funded by the National Institutes of Health includes asthma in the urban population, the investigation of immunologic responses to environmental exposures, and the study of risk factors and the natural history of asthma and allergic disease.

The Division of Cardiology specializes in complex cardiac conditions including valvular disease, cardiomyopathies, and arrhythmias. Four all-digital cardiac catheterization laboratories are located at Henry Ford Hospital, and additional state-of-the-art catheterization laboratories are located at Henry Ford West Bloomfield Hospital. Henry Ford Hospital has a 24-bed Cardiovascular Intensive Care Unit and 56 telemetry beds, as well as one of the most advanced Structural Heart Programs in the U.S.

The Department of Medicine’s Division of Cardiology and Division of Hypertension Research partner with the Department of Surgery’s Division of Vascular Surgery and Division of Cardiothoracic Surgery to align clinical, education, and research efforts within the Henry Ford Heart and Vascular Institute (HVI). As a service line across the Henry Ford Health System, the HVI provides the full spectrum of comprehensive cardiovascular care, from prevention, diagnosis, and medical management to interventional and surgical procedures including transplantation to cardiac rehabilitation and wellness. Research efforts from laboratory studies to clinical trials focus on how to reduce cardiac morbidity and mortality, with emphasis on new treatments for hypertension and renal disease, heart failure, structural heart therapies, and bridge therapies to heart transplantation.

Henry Ford’s Division of Endocrinology, Diabetes, and Bone and Mineral Disorders has long been one of the nation’s leaders in advancing clinical care for diabetes, thyroid disorders, pituitary disease, adrenal disease, and osteoporosis. The Division’s endocrinologists specialize in the diagnosis and treatment of common and complex endocrine conditions, including endocrine disorders in pregnancy, Cushing’s disease, pheochromocytoma, endocrine-related hypertension, and endocrine complications from the treatment of Hodgkin’s disease and other cancer. The Division has pioneered clinical research in diabetes and participates in advancing the understanding of bone and mineral disorders through ongoing laboratory research.

The Division of Gastroenterology at Henry Ford provides comprehensive services for the wide range of digestive disorders, from health screening to diagnostic and therapeutic endoscopy procedures, tissue and tumor biopsies, and advanced therapies for disease management. The Division offers a multidisciplinary Inflammatory Bowel Disease Center as well as a multidisciplinary Liver Disease Center. Gastroenterologists and hepatologists collaborate with the Henry Ford Transplant Institute, the Henry Ford Center for Cancer Surgery, and the Henry Ford Cancer Institute. Research efforts involve new methods for treatment of digestive disorders and liver disease.

The Hematology/Oncology Division at Henry Ford leads the medical treatment arm for the Henry Ford Cancer Institute as well as the bone marrow and stem cell transplantation program for the Henry Ford Transplant Institute. The bone marrow/stem cell transplant program is unique in Michigan for performing cord blood transplants. Medical oncologists participate in numerous tumor boards provided weekly at Henry Ford and continually offer advanced clinical trial therapies including biologics. The Hematology/Oncology Division participates in the Southwest Oncology Group funded by the National Cancer Institute and partners with others in the Henry Ford Cancer Institute’s research initiatives, such as the Cancer Epidemiology, Prevention and Control (CEPC) program. CEPC offers collaborative, multi-institutional research that addresses the entire cancer continuum, including the prevention, screening, diagnosis, treatment, and long-term outcomes of cancer.

The Division of Hospital Medicine at Henry Ford includes approximately 40 clinical hospitalists, 10 clinical physician educators, and several Palliative Medicine specialists. Hospitalists provide 24/7 coverage for Henry Ford Hospital Detroit, 60 beds at Henry Ford West Bloomfield Hospital and Henry Ford Wyandotte Hospital. . Hospitalists are involved in general inpatient medicine, perioperative medicine, observation care and consultative medicine. The Division leads the management of the Advanced Heart Failure Service for inpatients, such as heart transplant patients and those with left ventricular assist devices (LVADs). Research focuses on quality improvement processes. Hospitalists provide education, supervision, and training to residents rotating through the hospital medicine practice unit and the consultative medicine service. The Palliative Medicine team provides inpatient and ambulatory care. The team provides pain and symptom management of acute and chronic medical conditions as well as leads in goals of care discussions with patients and their families. The Palliative Medicine service provides education, supervision, and training to Palliative Medicine fellows as well as other fellows and residents rotating through the service.

The Hypertension and Vascular Research Division is devoted to basic and translational research to advance the understanding of the physiology of the renal-cardiovascular systems with an aim to reduce morbidity and mortality associated with hypertension and end organ damage. Long funded by the National Institutes of Health, the Division’s scientists are internationally known for expertise in transport physiology, cell biology, cardiac molecular biology, renal physiology and pathophysiology, cardiac physiology and pathophysiology, and genetic models of disease. The Division was founded by Oscar Carretero, M.D., who has received numerous awards for his research, including the 1997 Novartis Award for Hypertension Research from the American Heart Association’s Council for High Blood Pressure Research and the 2011 Robert Tigerstedt Award, a Distinguished Scientist Award from the American Society of Hypertension. The Division is presently composed of 8 staff investigators and 35 support personnel.

The Division of Infectious Diseases offers programs for antimicrobial stewardship, HIV/AIDS, transplant-related infections, infection prevention and epidemiology, as well as provides diagnosis and treatment for the full spectrum of infections related to bacteria, viruses, fungus, and parasites. Henry Ford’s Infectious Diseases Division was an early leader in HIV/AIDS clinical care and research, and participates in the Global Health Initiative with programs in Haiti, India, and Peru to assist in addressing critical health issues such as HIV/AIDS, tuberculosis, malaria, disease outbreaks, and other infections. Research in the Division of Infectious Diseases spans from basic to clinical research with a focus on HIV/AIDS, fungal infections, pathogenesis of wound infections, characterization of biofilms, transplant infectious disease, antimicrobial resistance, and nosocomial and community-acquired infections.

The Division of Academic Internal Medicine, based in Detroit on the Henry Ford Hospital campus, is a Center for Population Health and Education Innovation, both for patient care and medical education. We care for tens of thousands of patients and families yearly. At our Academic Patient-Centered Team Care clinic, we specialize in helping people live with complex and chronic conditions like high blood pressure and diabetes. Our staff physicians and residents lead care teams of specialized nurses, medical assistants, health psychologists, social workers, health educators, and community health workers. The teams seek to address each patient’s top medical, behavioral, and social needs. We are shaping the future of primary care for complex and chronic disease management through our academic patient-centered team care model, health services research, quality improvement activities, and training of physicians in our Internal Medicine Residency Program.

Henry Ford’s Division of Nephrology and Hypertension has a long history of excellence in the treatment of chronic kidney disease, diabetic kidney disease, hypertension, acid-base/electrolyte disorders, kidney-pancreas transplantation, and end-stage renal disease. The Division’s end-stage renal disease program is fully supported by its integration with Greenfield Health Systems, which facilitates quality improvement and clinical research in end-stage renal disease. Nephrologists conduct approximately 20,000 outpatient consultations, oversee 100,000 dialysis treatments, 500 new end-stage renal disease placements with vascular access interventions through its interventional nephrology section. Native and kidney transplant biopsies and peritoneal catheter placement are also performed. The Division supervises two Henry Ford Hospital floors dedicated to the care of patients with chronic kidney disease, a 16-bed inpatient hemodialysis unit and over 1,000 in-center hemodialysis patients. The Division is also integrated with the Henry Ford Transplant Institute’s multi-organ transplant program and participates in approximately 120 kidney and/or pancreas transplantations annually. The Division of Nephrology and Hypertension at Henry Ford also hosts a large clinical research enterprise that includes directed translational research in renal replacement therapies, investigator-initiated trials, and epidemiological investigations.

The Pulmonary and Critical Care Medicine Division at Henry Ford offers the most advanced therapies available for airways disease in the U.S., serving as a major referral center for complex lung diseases with the largest Medical ICU complex in Michigan. The Division has one of the largest lung cancer programs and one of the region’s only interventional pulmonologist staffed centers. The Division’s bronchoscopy suite provides state-of-the-art technology including airway stenting and endobronchial ultrasound-guided transbronchial needle biopsy. Multidisciplinary pulmonary treatment programs are provided for lung cancer, sarcoidosis, pulmonary fibrosis, and other lung diseases. A special inpatient lung floor is dedicated to the care of pulmonary disease patients at Henry Ford Hospital. Pulmonary clinical trial therapies sponsored by the NIH, American Lung Association, and other sources focus on advanced treatment for chronic obstructive pulmonary disease, sarcoidosis, pulmonary hypertension, sepsis, and respiratory failure. The Division partners with the Transplant Institute and the Center for Cancer Surgery at Henry Ford to provide the full spectrum of advanced therapies for lung diseases.

The Sleep Disorders Center at Henry Ford is one of the leading sleep laboratories in the world. Founded in 1978 as one of the first sleep disorders center in the U.S., the Henry Ford Sleep Disorders Center has consistently been ranked among the top funded research facilities for the scientific study of sleep. Investigators conduct research on all major sleep disorders. Separate bedroom laboratories are available for clinical and sleep research purposes. Dedication to research and patient care allows a variety of treatment options to be offered that are not available at many sleep centers.

The Division of Rheumatology at Henry Ford has a large clinical experience in the management of rheumatoid arthritis, osteoarthritis, and crystal-induced arthritic disorders; complex systemic immune-mediated syndromes, such as systemic lupus erythematosus, scleroderma, inflammatory muscle disease, and Sjogren's syndrome; and the systemic vasculitis syndromes such as giant cell arteritis and ANCA-associated syndromes. Among the first worldwide to focus on the specialty of rheumatology in the early 1950s, Henry Ford Hospital rheumatologists demonstrated first that gold injections were effective for rheumatoid arthritis and discovered via histomorphometry that osteoarthritis is associated with rheumatoid arthritis. Staining techniques developed at Henry Ford were used to measure bone turnover. NIH and pharmaceutical funded research focuses on finding new treatments including biologic compounds and immune modulating agents.